Loading...
OTCMIDTA
Market cap1mUSD
Dec 18, Last price  
0.45USD
Name

Identa Corp

Chart & Performance

D1W1MN
OTCM:IDTA chart
P/E
P/S
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
3.11%
Rev. gr., 5y
4.92%
Revenues
1m
-21.45%
429,071716,535412,427415,273826,9751,012,8221,449,8991,392,1361,338,7541,051,590
Net income
15k
-91.00%
-641,724-490,045-450,514-171,533142,86265,519354,44969,183162,71114,644
CFO
-138k
L
-765,678-270,736-240,542-75,255148,806-14,693431,791-88,94894,311-137,628

Profile

IDenta Corp. develops, manufactures, and supplies field detection and home diagnostics testing kits for narcotics and explosives, and forensic products in the homeland security and consumer markets worldwide. The company offers drug, explosives, and bullet-hole testing kits; FerroPrint testing products; blood detection kits; precursors of drugs test kits; and portable sniffers. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. IDenta Corp. was incorporated in 1997 and is headquartered in Jerusalem, Israel.
IPO date
Jun 21, 2001
Employees
Domiciled in
IL
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT